| | | Product | Registr. Holder | Package Size | Composition | CP | % | SB | DC |
|---|
| IP | CI | Metoject 15 mg | Gebro Pharma AG | syringe(s) | Injection solution: Methotrexatum 15mg / 0.3ml | 35.60 | | 10 % | |
| IP | CI | Metoject 7.5 mg | Gebro Pharma AG | syringe(s) | Injection solution: Methotrexatum 7.5mg / 0.15ml | 30.50 | -14% | 10 % | |
| IP | CI | Methotrexat Accord 7.5
mg/0.15 ml | Accord Healthcare AG | | Injection solution in prefilled syringe: Methotrexatum 7.5mg / 0.15ml | 30.60 | -14% | 10 % | |
| IP | | Methotrexat Accord 10
mg/0.2 ml | Accord Healthcare AG | | Injection solution in prefilled syringe: Methotrexatum 10mg / 0.2ml | 32.45 | -8% | 10 % | |
| IP | CI | Metoject 10 mg | Gebro Pharma AG | syringe(s) | Injection solution: Methotrexatum 10mg / 0.2ml | 32.85 | -7% | 10 % | |
| IP | | Methotrexat Accord 12.5
mg/0.25 ml | Accord Healthcare AG | | Injection solution in prefilled syringe: Methotrexatum 12.5mg / 0.25ml | 33.65 | -5% | 10 % | |
| IP | CI | Metoject 12.5 mg | Gebro Pharma AG | syringe(s) | Injection solution: Methotrexatum 12.5mg / 0.25ml | 34.65 | -2% | 10 % | |
| IP | | Methotrexat Accord 15
mg/0.3 ml | Accord Healthcare AG | | Injection solution in prefilled syringe: Methotrexatum 15mg / 0.3ml | 34.90 | -1% | 10 % | |
| IP | | Methotrexat Accord 17.5
mg/0.35 ml | Accord Healthcare AG | | Injection solution in prefilled syringe: Methotrexatum 17.5mg / 0.35ml | 36.00 | +1% | 10 % | |
| IP | | Methotrexat Accord 20
mg/0.4 ml | Accord Healthcare AG | | Injection solution in prefilled syringe: Methotrexatum 20mg / 0.4ml | 37.10 | +4% | 10 % | |
| IP | CI | Metoject 17.5 mg | Gebro Pharma AG | syringe(s) | Injection solution: Methotrexatum 17.5mg / 0.35ml | 37.40 | +5% | 10 % | |
| IP | | Methotrexat Accord 22.5
mg/0.45 ml | Accord Healthcare AG | | Injection solution in prefilled syringe: Methotrexatum 22.5mg / 0.45ml | 38.40 | +7% | 10 % | |
| IP | CI | Metoject 20 mg | Gebro Pharma AG | syringe(s) | Injection solution: Methotrexatum 20mg / 0.4ml | 38.50 | +8% | 10 % | |
| IP | | Methotrexat Accord 25
mg/0.5 ml | Accord Healthcare AG | | Injection solution in prefilled syringe: Methotrexatum 25mg / 0.5ml | 39.75 | +11% | 10 % | |
| IP | CI | Metoject 22.5 mg | Gebro Pharma AG | syringe(s) | Injection solution: Methotrexatum 22.5mg / 0.45ml | 40.20 | +12% | 10 % | |
| IP | CI | Metoject 25 mg | Gebro Pharma AG | syringe(s) | Injection solution: Methotrexatum 25mg / 0.5ml | 41.20 | +15% | 10 % | |
| IP | | Methotrexat Accord 27.5
mg/0.55 ml | Accord Healthcare AG | | Injection solution in prefilled syringe: Methotrexatum 27.5mg / 0.55ml | 41.55 | +16% | 10 % | |
| IP | | Methotrexat Accord 30
mg/0.6 ml | Accord Healthcare AG | | Injection solution in prefilled syringe: Methotrexatum 30mg / 0.6ml | 43.25 | +21% | 10 % | |
| IP | CI | Metoject 30 mg | Gebro Pharma AG | syringe(s) | Injection solution: Methotrexatum 30mg / 0.6ml | 45.15 | +26% | 10 % | |
| IP | CI | Metoject 10 mg | Gebro Pharma AG | | Injection solution: Methotrexatum 10mg / 0.2ml | PR | | k.A. | |
| IP | CI | Metoject 12.5 mg | Gebro Pharma AG | | Injection solution: Methotrexatum 12.5mg / 0.25ml | PR | | k.A. | |
| IP | CI | Metoject 15 mg | Gebro Pharma AG | | Injection solution: Methotrexatum 15mg / 0.3ml | PR | | k.A. | |
| IP | CI | Metoject 17.5 mg | Gebro Pharma AG | | Injection solution: Methotrexatum 17.5mg / 0.35ml | PR | | k.A. | |
| IP | CI | Metoject 20 mg | Gebro Pharma AG | | Injection solution: Methotrexatum 20mg / 0.4ml | PR | | k.A. | |
| IP | CI | Metoject 22.5 mg | Gebro Pharma AG | | Injection solution: Methotrexatum 22.5mg / 0.45ml | PR | | k.A. | |
| IP | CI | Metoject 25 mg | Gebro Pharma AG | | Injection solution: Methotrexatum 25mg / 0.5ml | PR | | k.A. | |
| IP | CI | Metoject 27.5 mg | Gebro Pharma AG | syringe(s) | Injection solution: Methotrexatum 27.5mg / 0.55ml | PR | | k.A. | |
| IP | CI | Metoject 27.5 mg | Gebro Pharma AG | | Injection solution: Methotrexatum 27.5mg / 0.55ml | PR | | k.A. | |
| IP | CI | Metoject 30 mg | Gebro Pharma AG | | Injection solution: Methotrexatum 30mg / 0.6ml | PR | | k.A. | |
| IP | CI | Metoject 7.5 mg | Gebro Pharma AG | | Injection solution: Methotrexatum 7.5mg / 0.15ml | PR | | k.A. | |
